Approximately 120 million individuals are affected by lymphatic filariasis worldwide, 107 million of whom are parasitized by Wuchereria bancrofti and 13 million are parasitized by Brugia malayi (18) . Epidemiological evidence suggests that exposure to infective larvae (L 3 ) stimulates protective immunity (4) . In addition, a large proportion of individuals living in areas of endemic infection (endemic individuals) appear to be free of microfilariae and adult worms, although they possess antifilarial antibodies and therefore have been exposed to parasitism (16, 17, 23) . These individuals, commonly described as asymptomatic endemic normals, are presumed to be resistant to L 3 infection. The characterization of antigens from the infectious stage that induce a specific response in resistant as opposed to parasitized individuals is a crucial step in understanding early resistance to filarial development and in searching for vaccine candidates (6) . More directly, this should help in designing diagnostic tools for W. bancrofti and especially for B. malayi, for which sensitive tools for detecting cryptic parasitism are lacking (18) . In this study, we have identified paramyosin as a major immunodominant antigen of infective larvae (L 3 ) of B. malayi and studied the antibody responses to the recombinant paramyosin of individuals exposed to W. bancrofti transmission in terms of their parasitological status.
MATERIALS AND METHODS

Study populations.
A total of 123 patients were recruited among the adult population (Ͼ20 years old) of the island Tahaa, Society Archipelago, French Polynesia. This island has ca. 4,000 inhabitants, and a recent survey, conducted in the course of a large-scale chemotherapy assay, indicated that 22% of adult individuals had microfilariae (Mf) (13) ; 46% had Og4C3 circulating antigen and were thus suspected of harboring W. bancrofti adult worms (17) . The patients were surveyed for a history of filariasis, given a physical examination, and screened for microfilaremia by filtration of 1 ml of venous blood. Blood was collected during the day, since W. bancrofti var. pacifica is subperiodic in French Polynesia (14) . Sera were separated by centrifugation and frozen at Ϫ30°C until use. All sera were screened for the presence of adult worm circulating filarial antigen (CFA) by an Og4C3 enzyme-linked immunosorbent assay (ELISA) (12) as recommended by the manufacturer (JCU Tropical Biotechnology Pty Ltd., Brisbane, Australia). The limit for positivity was 100 U of Og4C3 antigen per ml. All endemic individuals recruited were checked for positive antifilarial serology (anti-adult Brugia malayi immunoglobulin G (IgG) (7) to determine their exposure to W. bancrofti parasitism. Nine sera from European adults who had never lived in a filariasis-endemic area and were negative for the three markers were used as the negative control (nonendemic subjects). Endemic individuals were classified into three groups: (i) Mf carriers (Mf and CFA positive), (ii) amicrofilaremic adult worm carriers (Mf negative but CFA positive), and (iii) unparasitized subjects (Mf and CFA negative). The mean age of all individuals enrolled was 48.1 years old (range, 21 to 81 years), the sex ratio was 0.48 (female/male), and the three groups were not significantly different for these two parameters.
All individuals were treated twice with a single annual dose of ivermectin at 400 g/kg plus diethylcarbamazine at 3 mg/kg (13) . Blood was collected before the first treatment (month 0), 1 year after the first treatment and just before the second treatment (month 12), and 1 year after the second treatment (month 24). Mf and CFA levels were determined at each of the three time points.
Parasite extracts and antisera. Protein extracts were prepared from Mf or L 3 larvae of W. bancrofti and from B. malayi adult worms as follows. W. bancrofti L 3 larvae were obtained from Aedes polynesiensis mosquitoes previously fed on human blood collected from a microfilaremic individual. Mf were purified from human blood on a Percoll gradient (Sigma Co., St. Louis, Mo.). B. malayi adult worms were provided by E. A. Ottesen (National Institutes of Health, Bethesda, Md.). All parasites were kept in phosphate-buffered saline (PBS) and stored at Ϫ30°C before use. Crude protein extracts were made by sonicating the parasites in PBS, and the protein concentration was determined after centrifugation by the bicinchoninic acid protein assay (Pierce, Rockford, Ill.). Mouse polyclonal serum was raised against each filarial stage in BALB/c mice by one intraperitoneal injection of 50 g of protein extract in complete Freund's adjuvant, followed by three intraperitoneal injections of 50 g of protein in incomplete Freund adjuvant at 2-to 3-week intervals. The mice were bled 1 week after the last injection.
Isolation of paramyosin cDNA. A B. malayi L 3 cDNA library constructed in the lambda UniZap XR vector (Stratagene) was provided by S. A. Williams, Smith College, Northampton, Mass. (SAW94WL-BmL3 library) (2) and screened with the antiserum raised against W. bancrofti L 3 . Immunoscreening was performed with horseradish peroxidase-labelled goat anti-mouse IgG heavy plus light chain (Biosys) as the secondary antibody and developed with ␣-chloronaphthol. The positive clones were purified by repeated cycles of immunoscreening, and the size of the B. malayi cDNA inserts was determined by PCR with T3 and T7 pBluescript primers. Recombinant pBluescript plasmids were excised from positive phages, and partial nucleotide sequencing of the 5Ј and 3Ј ends of the inserts was performed with the Circumvent thermal cycle DNA sequencing kit (New England Biolabs, Beverly, Mass.).
Sequence analysis. Two inserts of 3 kb (BmILM5) and 2.1 kb (BmILM6), which showed high homology to paramyosins from other filarial species, were selected, and their nucleotide sequence was determined with the Circumvent thermal cycle DNA sequencing kit and ExoVent polymerase (New England Biolabs). Sequencing of full-length cDNA in both directions was done with synthetic primers (Genosys, Cambridge, United Kingdom) designed from the paramyosin nucleotide sequences of Onchocerca volvulus and B. malayi cDNAs. Initial assembly of the cDNA sequences and amino acid translations were performed with the sequence analysis software PC-Gene (IntelliGenetics Inc., Mountain View, Calif.). The nucleotide and protein sequences were compared with all other sequences in database searches with the BLASTN and the BLASTX search programs (1) . One of the cDNAs (BmILM5) encoded the full-length paramyosin of B. malayi.
Expression and purification of recombinant paramyosins. The coding sequences of BmILM5 and BmILM6 cDNAs were amplified by PCR with the forward primer 5Ј-GCGGATCCGATGTCCGGTTCAC-3Ј and the reverse primer 5Ј-CGCGAAGCTTGGGTACCGGGCCC-3Ј. The PCR products were subcloned between the BamHI and HindIII sites of the expression plasmid vector pGEX-FA (derived from pGEX-3T, a gift from F. Laurent, Nouzilly, France), downstream of the glutathione S-transferase (GST) coding sequence. Sequences at the sites of ligations were checked by sequencing with 3Ј-pGEXRev and 5Ј-pGEXFor primers (Pharmacia, Uppsala, Sweden). Recombinant GST fusion proteins were expressed in Escherichia coli DH5␣ after induction with 1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). Expression of recombinant fusion proteins was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (11% polyacrylamide gels) of lysed bacterial cell pellets. Recombinant proteins were visualized by Coomassie blue staining and by using anti-GST polyclonal rabbit antibody after transfer onto nitrocellulose membranes (Hybond-ECL; Amersham, Arlington Heights, Ill.). Bacterial cultures were sonicated, and GST fusion proteins (and control GST) were purified by affinity chromatography with glutathione agarose by the protocols described by the manufacturer (Pharmacia). The homogeneity of purified proteins was checked by SDS-PAGE and Coomassie blue staining, and the protein concentration was determined by the bicinchoninic acid protein assay (Pierce).
ELISAs with recombinant paramyosin and human sera. The sera from endemic and nonendemic individuals were screened for total IgG or IgG isotype reactivity to recombinant BmILM6 truncated paramyosin as follows. Microtiter plates (Luxlon@ M29 LES; CEB) were coated in parallel with purified GSTBmILM6 fusion protein or purified GST at 0.1 g/well for IgG assays or 0.5 g/well for IgG subclass assays. The plates were incubated for 2 h at 37°C, stored overnight at 4°C, and blocked before use in ELISA by a 2-h incubation in 0.05% Tween 20-10% goat serum in PBS. After the plates were washed with 0.05% Tween 20 in PBS, patient sera diluted 1/100 in the same diluent (ELISA diluent) were added in duplicate, and the plates were incubated for 2 h at 37°C. The plates were washed before the addition of murine monoclonal anti-human IgG Fc (clone HP 6017; Sigma) diluted 1/1,000. After a 2-h incubation at room temperature (ca. 25°C), all the wells were washed and received a 1/2,000 horseradish peroxidase-conjugated rabbit anti-mouse reagent (Biosys); the plates were then incubated for 2 h at room temperature. After the plates were washed, o-phenylenediamine substrate (OPDA; Sigma) was added to each well for 30 min and the optical density (OD) was recorded at 492 nm. Preliminary assays to determine the appropriate dilutions of patient serum, antibodies, horseradish peroxidase and conjugates were carried out with a pool of 15 sera from microfilaremic Polynesian individuals used as positive controls and a pool of 5 sera from nonendemic European individuals as negative controls. The ELISA for IgG isotype analysis was carried out similarly, with the following isotype-specific mouse monoclonal antibodies (Sigma): IgG1, clone HP-6001; IgG2, clone HP-6002; IgG3, clone HP-6047; and IgG4, clone HP-6023 (all used at a dilution 1/2,000).
Positive and negative sera were included on all plates and used to adjust for minor plate-to-plate variations. The arithmetic mean of the OD from duplicate wells coated with GST were subtracted from the OD means from wells coated with GST-BmILM6 to give a net OD. The cutoff levels were defined as the arithmetic means Ϯ 2 SD of the antibody activities of sera from nonendemic individuals. Anti-paramyosin IgG4 titers of positive sera were measured at a range of four or more dilutions by comparison to a standard curve obtained with the same pool of 15 microfilaremic individuals mentioned above.
Statistical analysis. Differences in net OD means between patient groups were analyzed by the Student t test or analysis of variance. Correlation between covariates was analyzed by Spearman's correlation test. Statistical significance by any of these methods was inferred as P Ͻ 0.05.
Nucleotide sequence accession number. The sequence of the BmILM5 cDNA was submitted to GenBank under accession no. U77590.
RESULTS
Analysis of full-length paramyosin cDNA. About 100,000 recombinant phages were screened with the anti-B. malayi L 3 mouse polyclonal antiserum. Twelve strongly positive clones were purified for further analysis. The insert sizes, determined by PCR with T3 and T7 primers, were mostly of 3 kb, except for one insert, which was 2.1 kb. Partial sequencing and restriction enzyme analysis indicated that all recombinant plasmids had similar 5Ј-end nucleotide sequences and all had strong homologies to the paramyosin of O. volvulus. Therefore, two clones with inserts of 2.1 and 3 kb (referred to as clones BmILM6 and BmILM5) were selected for complete nucleotide sequencing. Clone BmILM5 contained the full-length cDNA of B. malayi paramyosin and consisted of an open reading frame of 2,640 nucleotides predicted to encode 880 amino acids containing a 97-kDa protein. Alignments of BmILM5 and all other sequences in GenBank showed 96% protein homology to the paramyosin of two other filarial parasites, O. volvulus (accession no. M95813) and Dirofilaria immitis (J04009). This is schematically represented in Fig. 1 . BmILM5 differed from the paramyosin sequences of the other species at the COOH-terminal end, with two divergent blocks in the last 150 amino acids. The nucleotide sequence of BmILM6 was identical to that of BmILM5 but lacked 699 nucleotides at the 3Ј end and therefore encoded a protein of only 647 amino acids.
Expression of GST fusion paramyosin. The cDNAs of BmILM5 and BmILM6 were subcloned into the pGEX-FA expression vector to produce GST fusion proteins. E. coli cells transformed with pGEX-FA/BmILM5 produced a single fusion protein with a molecular mass of about 97 kDa when reacted with W. bancrofti L 3 antiserum and with other filarialstage antisera and anti-GST antiserum (data not shown). The GST-BmILM5 protein is smaller than the predicted size of the fusion protein (126 kDa), indicating that the protein was not fully expressed or that the product was unstable. In contrast, E. coli cells transformed with pGEX-FA/BmILM6 produced a major 100-kDa fusion protein, as expected, and two minor bands at 76 and 60 kDa, recognized by anti-GST antibodies (data not shown), suggesting that they are proteolysis products of the 100-kDa fusion protein. The three proteins were also recognized by antibodies raised against W. bancrofti L 3 , W. bancrofti Mf, or B. malayi adult worms (data not shown). The recombinant GST expressed in bacterial cells transformed with pGEX-FA alone was not recognized by antifilarial antisera. No reactivity was observed with nonimmune mouse serum, showing that recombinant paramyosin was specifically recognized by filaria-infected hosts. The 100-kDa GST-BmILM6 fusion protein and the GST were purified with glutathione-agarose. Their homogeneity were checked by SDS-PAGE and Coomassie blue staining (Fig. 2) .
Antibody responses of W. bancrofti endemic individuals to GST-BmILM6. Since expression of the full-length cDNA fragment (BmILM5) was inadequate in pGEX-FA, we used recombinant truncated paramyosin (GST-BmILM6) to analyze the humoral response of endemic individuals to paramyosin.
None of the nonendemic individuals had isotype antibody responses to BmILM6. The reactivity of the sera from endemic individuals to paramyosin is illustrated in Fig. 3 . All endemic individuals recruited in this study had been exposed to W. bancrofti parasites since all had anti-filarial IgG, as evaluated by ELISA with B. malayi adult worm extract (data not shown). The percentage of endemic individuals positive for antiparamyosin IgG ranged from 75 to 90%, but the level of IgG was significantly higher in individuals who had only W. bancrofti adult worms than in individuals with Mf or unparasitized individuals (P Ͻ 0.05). IgG1, IgG2, and IgG3 antibody responses of the three groups to BmILM6 were low (mean OD, Ͻ 0.1), and the proportion of positive individuals ranged from 0 to 17%. In contrast, the IgG4 antibody response showed an interesting pattern. The presence of paramyosin-reactive IgG4 was observed only in parasitized individuals (35% of Mf-positive individuals and 50% of Mf-negative, CFA-positive individuals), with a significantly higher response in Mf-negative, CFA-positive individuals (P Ͻ 0.01). The level of CFA in Mf-positive individuals was four times higher than that in Mfnegative individuals. There was a negative correlation between the CFA level in parasitized individuals (Mf positive and negative, n ϭ 26) and the paramyosin-reactive IgG4 level (r ϭ Ϫ0.55). However, no correlation was observed between paramyosin-reactive IgG4 level and Mf status. Neither the CFA level nor the paramyosin-reactive IgG4 level was correlated with the age of the individuals.
Decline of anti-paramyosin antibody levels after chemotherapy. The decrease in paramyosin-reactive IgG4 titers was monitored after each of two annual treatments with diethylcarbamazine (3 mg/kg) and ivermectin (400 g/kg) in parasitized individuals who were anti-paramyosin IgG4 positive before treatment (n ϭ 26). There was a sharp and continuous reduction in anti-paramyosin IgG4 titers, which was highly correlated (r ϭ 0.99) with the reduction in the adult worm burden (Table 1) . 
DISCUSSION
Immunoscreening a cDNA library from infective larvae of B. malayi has confirmed that paramyosin is a major immunodominant antigen in infective larvae. We have cloned and sequenced the full-length cDNA encoding B. malayi paramyosin. This protein shows 96% amino acid identity to the paramyosin of two other filarial parasites, D. immitis, the dog heartworm (5), and O. volvulus, the etiological agent of river blindness in humans (11) . The D. immitis and O. volvulus proteins have 99% amino acid identity. The less conserved part of the protein is the carboxy-terminal end. The sequence of the cDNA isolated here confirms the partial cDNA sequence of B. malayi paramyosin already published by Li et al. (9) , which was restricted to amino acids 251 to 659. The paramyosin cDNA from B. malayi showed only 33% homology to paramyosin cDNAs of the trematodes Schistosoma mansoni and S. japonicum (19, 24) .
Paramyosin has been characterized as a myofibrillar protein found only in invertebrates. In B. malayi, it is located within the longitudinal somatic musculature of L 3 , L 4 , and adult worms (21) . Here we show that it is expressed in Mf as well. In an attempt to search for protective antigens in filarial infections, Nanduri and Kazura (15) observed that paramyosin immunization of mice could induce the clearance of B. malayi Mf. Moreover, B. malayi recombinant truncated paramyosin conferred partial protection against infection in immunized jirds (10) . Therefore, paramyosin is considered a candidate component for a vaccine to prevent the development of filariasis. Paramyosin is also a strong candidate for a vaccine for S. mansoni infections, where both native and recombinant forms of paramyosin have been shown to be immunogenic and to confer protective immunity in mice (8, 19, 20) . In addition, nucleic acid vaccination with the paramyosin coding sequence elicited the production of anti-paramyosin antibodies in mice (25) .
Attempts to express the entire coding region in the pGEX-FA expression vector were unsuccessful, because of either premature termination or proteolysis in E. coli. However, the truncated form of recombinant paramyosin (the amino-terminal end) reacted strongly with sera directed against each stage of the filarial parasites W. bancrofti and B. malayi. The cross-reactivity between B. malayi paramyosin and antisera raised against W. bancrofti can be explained by the high homology between B. malayi and W. bancrofti paramyosin sequences (23a). Steel et al. (22) have reported that the main domain of O. volvulus paramyosin reactivity is located at the first 120 amino acids of the molecule. This is consistent with our results, since BmILM6 lacked 699 nucleotides (233 amino acids) at its 3Ј end, the region shown to be divergent in filarial species (7) .
Although the sequence of paramyosin from B. malayi was highly homologous to that of paramyosin from O. volvulus, the pattern of humoral responses of Polynesian individuals was different from that observed with O. volvulus-endemic individuals from Guatemala or Ghana (22) . Individuals living in areas of endemic onchocerciasis infection had a strong IgG3 response but a very weak IgG4 response. In our study, lymphatic filariasis-endemic individuals had a strong IgG4 response while other isotypes were poorly reactive. The most interesting data from our study was the specific IgG4 response in individuals parasitized with W. bancrofti (Mf and/or adult worms) and the lack of response in parasite-free individuals (commonly referred to as putatively immune individuals). By contrast, Polynesian individuals who are free of W. bancrofti parasitism (Mf and Og4C3 antigen negative), although subjected to transmission, can harbor IgG4 reacting with crude filarial extracts (17a). Therefore, the specificity of the anti-paramyosin IgG4 response with parasitism and the correlation of anti-paramyosin IgG4 titers and reduction of adult worm antigen following chemotherapy make paramyosin-reactive IgG4 detection a good marker of parasitism and efficacy of control. Due to the high homology of the B. malayi and W. bancrofti antigens, it is likely that the recombinant antigen identified in our work will be useful for diagnosis of B. malayi as well. In particular, it may be useful to detect cryptic parasitism due to adult worms. Other recombinant B. malayi antigens that raise an IgG4 response have also been identified as markers of parasitism in brugian and bancroftian filariasis (3) , and further studies must be carried out in this direction to design a cocktail of recombinant antigens sensitive enough for a B. malayi parasitism survey, as has been done for O. volvulus.
